First-line treatment of papillary renal cell carcinoma with sunitinib
Papillary renal cell carcinoma (PRCC) is a rare subtype of [...]
Papillary renal cell carcinoma (PRCC) is a rare subtype of [...]
A paper published in The Oncologist last month analysed real-world [...]
A recent literature review and network meta-analysis of phase 2/3 [...]
Approval of axitinib plus pembrolizumab and axitinib plus avelumab in [...]
A retrospective study of the use of targeted therapies for [...]
In this paper, three clinical trials with immunotherapy combinations for [...]
Non-clear cell renal cell carcinoma (RCC) and sarcomatoid renal cell [...]
A recent study looked at the impact of stopping sunitinib [...]
This interview with Dr Monty Pal, Associate Professor from the [...]
Results from the JAVELIN Renal 101 study to evaluate avelumab [...]